PL373331A1 - Sposób wytwarzania sterylnej zawiesiny cząstek kortykosteroidu do podawania drogą inhalacji - Google Patents

Sposób wytwarzania sterylnej zawiesiny cząstek kortykosteroidu do podawania drogą inhalacji

Info

Publication number
PL373331A1
PL373331A1 PL03373331A PL37333103A PL373331A1 PL 373331 A1 PL373331 A1 PL 373331A1 PL 03373331 A PL03373331 A PL 03373331A PL 37333103 A PL37333103 A PL 37333103A PL 373331 A1 PL373331 A1 PL 373331A1
Authority
PL
Poland
Prior art keywords
inhalation
administration
preparation
sterile suspension
corticosteroid particles
Prior art date
Application number
PL03373331A
Other languages
English (en)
Other versions
PL207863B1 (pl
Inventor
Barbara Sambuco
Daniele Pirrotta
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of PL373331A1 publication Critical patent/PL373331A1/pl
Publication of PL207863B1 publication Critical patent/PL207863B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
PL373331A 2002-04-17 2003-04-15 Sposób wytwarzania wodnych zawiesin stosowanych w kompozycjach farmaceutycznych do inhalacji drogą nebulizacji PL207863B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000808A ITMI20020808A1 (it) 2002-04-17 2002-04-17 Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione

Publications (2)

Publication Number Publication Date
PL373331A1 true PL373331A1 (pl) 2005-08-22
PL207863B1 PL207863B1 (pl) 2011-02-28

Family

ID=11449718

Family Applications (1)

Application Number Title Priority Date Filing Date
PL373331A PL207863B1 (pl) 2002-04-17 2003-04-15 Sposób wytwarzania wodnych zawiesin stosowanych w kompozycjach farmaceutycznych do inhalacji drogą nebulizacji

Country Status (25)

Country Link
US (1) US7541021B2 (pl)
EP (1) EP1494647B1 (pl)
CN (1) CN1292733C (pl)
AR (1) AR039317A1 (pl)
AT (1) ATE338539T1 (pl)
AU (1) AU2003227627A1 (pl)
BR (1) BRPI0304821B8 (pl)
CA (1) CA2481520C (pl)
CY (1) CY1105800T1 (pl)
DE (1) DE60308164T2 (pl)
DK (1) DK1494647T3 (pl)
EA (1) EA007629B1 (pl)
ES (1) ES2272987T3 (pl)
HK (1) HK1079986B (pl)
HR (1) HRP20040964A2 (pl)
IT (1) ITMI20020808A1 (pl)
MA (1) MA27194A1 (pl)
MX (1) MXPA04010117A (pl)
PE (1) PE20030948A1 (pl)
PL (1) PL207863B1 (pl)
PT (1) PT1494647E (pl)
SI (1) SI1494647T1 (pl)
UA (1) UA79453C2 (pl)
WO (1) WO2003086347A1 (pl)
ZA (1) ZA200408319B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879833B2 (en) * 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
UA82561C2 (uk) * 2003-10-23 2008-04-25 Оцука Фармасьютикалз Ко., Лтд. Стерильна ін'єкційна композиція арипіпразолу з контрольованим вивільненням, спосіб її виготовлення та спосіб лікування шизофренії
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070134165A1 (en) * 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
EP1683514B1 (en) 2005-01-20 2012-05-23 Eratech S.r.l. Process for the preparation of concentrated suspensions of drugs and kit thereof
CA2622758A1 (en) * 2005-09-15 2007-03-29 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
JP2009526858A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー コルチコステロイド溶液を製造する方法
HRP20161388T1 (hr) * 2007-06-22 2016-12-02 Dompé Farmaceutici S.P.A. Šumeće tablete namijenjene upotrebi u inhalatoru
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
SI2170279T1 (en) * 2007-07-31 2018-04-30 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
CN102475708A (zh) * 2010-11-23 2012-05-30 天津金耀集团有限公司 丙酸氟替卡松和含辅料的水构成的治疗皮肤病的分离式水混悬剂药物
CN102657659A (zh) * 2010-11-23 2012-09-12 天津金耀集团有限公司 皮肤用含有辅料的丙酸氟替卡松与含有辅料的水的透皮吸收药物
ES2612257T3 (es) 2011-05-03 2017-05-16 Chiesi Farmaceutici S.P.A. Formulación de suspensión mejorada de dipropionato de beclometasona para administración mediante inhalación
CN103505412A (zh) * 2012-06-26 2014-01-15 上海臣邦医药科技有限公司 一种吸入用丙酸氟替卡松混悬液的制备方法
WO2022098321A1 (en) * 2020-11-09 2022-05-12 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilised suspensions for the administration by inhalation
WO2022231531A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2022231533A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization
WO2023022672A2 (en) * 2021-08-18 2023-02-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of homogeneous suspensions for the inhalation by nebulization
WO2024180569A1 (en) * 2023-03-01 2024-09-06 Ajaykumar Balraj Kanduri A synergistic aqueous nebulization suspension for management of infectious respiratory disorders and process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1303692B1 (it) * 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.

Also Published As

Publication number Publication date
MA27194A1 (fr) 2005-01-03
AR039317A1 (es) 2005-02-16
PE20030948A1 (es) 2004-01-19
HK1079986A1 (en) 2006-04-21
ITMI20020808A0 (it) 2002-04-17
ITMI20020808A1 (it) 2003-10-17
DE60308164D1 (de) 2006-10-19
ES2272987T3 (es) 2007-05-01
HRP20040964A2 (en) 2005-02-28
CN1292733C (zh) 2007-01-03
WO2003086347A1 (en) 2003-10-23
EA007629B1 (ru) 2006-12-29
EA200401209A1 (ru) 2005-10-27
BRPI0304821B1 (pt) 2018-11-06
ATE338539T1 (de) 2006-09-15
MXPA04010117A (es) 2004-12-13
SI1494647T1 (sl) 2007-02-28
HK1079986B (zh) 2007-05-11
CN1652748A (zh) 2005-08-10
CY1105800T1 (el) 2011-02-02
EP1494647A1 (en) 2005-01-12
CA2481520C (en) 2011-02-22
UA79453C2 (en) 2007-06-25
EP1494647B1 (en) 2006-09-06
PT1494647E (pt) 2007-01-31
DE60308164T2 (de) 2007-08-09
BR0304821A (pt) 2004-06-15
BRPI0304821B8 (pt) 2021-05-25
CA2481520A1 (en) 2003-10-23
PL207863B1 (pl) 2011-02-28
ZA200408319B (en) 2006-03-29
US7541021B2 (en) 2009-06-02
DK1494647T3 (da) 2007-01-15
AU2003227627A1 (en) 2003-10-27
US20050175546A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
SI1494647T1 (sl) Postopek za pripravo sterilne suspenzije kortikosteroidnih delcev za aplikacijo z inhalacijo
TWI315203B (en) Process for producing sterile suspensions of slightly soluble basic peptide complexes, sterile suspensions of slightly soluble basic peptide complexes, pharmaceutical formulations containing them, and the use thereof as medicaments
HUP0104230A3 (en) A process for the preparation of suspensions of drug particles for inhalation delivery
HUS1400011I1 (hu) Új gyógyszer krónikus elzáródásos tüdõbetegség kezelésére
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
SI1656346T1 (sl) 1,2,3,4-tetrasubstituiran indol za zdravljenje respiratornih bolezni
TWI371274B (en) Process for making sterile aripiprazole of desired mean particle size
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
IL179611A (en) History 1-Aza-bicycloalkyl, their process, their pharmaceutical preparations and their use in the preparation of drugs for the treatment of psychotic disorders
TWI345975B (en) Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
AU2002316771A1 (en) Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
AU2003294879A1 (en) Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
EP1585500B8 (en) Coated particles for sustained-release pharmaceutical administration
AU2003279240A8 (en) Methods for purifying viral particles for gene therapy
SG149876A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
AU2002338303A1 (en) Therapeutic compositions for the treatment of a respiratory tract disease
MY143364A (en) Method for producing tiotropium salts
IL162510A0 (en) Pharmaceutical suspension for oral administration
AU2003294100A1 (en) Use of hyaluronic acid for respiratory disorders or the upper airways
AU2003213402A1 (en) Powdery medicinal compositions for inhalation and process for producing the same
AU2003212351A8 (en) A process for the preparation of cephalosporan acid derivatives from cephalosporin c
HUP0400925A3 (en) Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU2003252479A1 (en) Remedies for respiratory diseases
AU2002348105A1 (en) Oral dosage forms for improving the bioavailability of therapeutic agents

Legal Events

Date Code Title Description
RECP Rectifications of patent specification